Plante Moran Financial Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31
Closed -$1.27K 808
2023
Q2
$1.27K Hold
31
﹤0.01% 717
2023
Q1
$1.78K Hold
31
﹤0.01% 714
2022
Q4
$1.74K Hold
31
﹤0.01% 748
2022
Q3
$1K Hold
31
﹤0.01% 820
2022
Q2
$2K Hold
31
﹤0.01% 817
2022
Q1
$2K Hold
31
﹤0.01% 743
2021
Q4
$2K Hold
31
﹤0.01% 913
2021
Q3
$2K Hold
31
﹤0.01% 865
2021
Q2
$2K Hold
31
﹤0.01% 879
2021
Q1
$2K Hold
31
﹤0.01% 913
2020
Q4
$2K Hold
31
﹤0.01% 775
2020
Q3
$1K Hold
31
﹤0.01% 809
2020
Q2
$1K Hold
31
﹤0.01% 706
2020
Q1
$1K Hold
31
﹤0.01% 692
2019
Q4
$2K Hold
31
﹤0.01% 689
2019
Q3
$2K Hold
31
﹤0.01% 777
2019
Q2
$2K Hold
31
﹤0.01% 728
2019
Q1
$2K Hold
31
﹤0.01% 716
2018
Q4
$1K Hold
31
﹤0.01% 804
2018
Q3
$2K Hold
31
﹤0.01% 697
2018
Q2
$2K Hold
31
﹤0.01% 726
2018
Q1
$2K Buy
+31
New +$1.63K ﹤0.01% 840
2017
Q1
Sell
-64
Closed -$3K 941
2016
Q4
$3K Buy
64
+12
+23% +$488 ﹤0.01% 801
2016
Q3
$2K Sell
52
-18
-26% -$754 ﹤0.01% 836
2016
Q2
$3K Hold
70
﹤0.01% 723
2016
Q1
$2K Buy
+70
New +$2.18K ﹤0.01% 725

Other funds holding IART

Plante Moran Financial Advisors's IART Position: Q3 2023 in Review

Plante Moran Financial Advisors sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 31 shares — an estimated $1.27K sold.

Plante Moran Financial Advisors first reported a position in IART in Q1 2016 and held it in 26 quarters. The position peaked at $3K in Q4 2016. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Plante Moran Financial Advisors reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 31 Integra LifeSciences shares in Q3 2023, an estimated $1.27K.
  • Plante Moran Financial Advisors first reported a position in Integra LifeSciences in Q1 2016 and held it in 26 quarters.
  • Plante Moran Financial Advisors's Integra LifeSciences position peaked at $3K in Q4 2016.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.